Since one of the attractions of gene therapy in the heart is week in the noninfarcted area, whereas little fluorescence the implantation of genetically modified cultured cells, we was detected in the area of infarction. This observation was employed genetically modified myocytes transfected with confirmed by measurement of fluorescence, which showed FITC-labeled oligodeoxynucleotides (ODN) and ␤-galactosignificantly higher levels in the noninfarcted area than the sidase gene in this study, to investigate the cellular localizinfarcted area. Positive staining for ␤-galactosidase protein ation and fate of grafted myocytes in the heart. In addition, was also clearly observed 7 days after grafting of transfecwe examined the feasibility of myocytes grafting into a tion of the ␤-galactosidase gene, while no staining was myocardial infarction model. Delivery of FITC-labeled ODN detected in grafted myocytes in control rats. Survival of with the HVJ-liposome method resulted in sustained fluimplanted genetically modified cardiac myocytes in the orescence as compared to direct transfer of 'naked' ODN.
Introduction otides (ODN) and ␤-galactosidase gene, to investigate the Recent progress in molecular biology has opened the cellular localization and fate of grafted myocytes in the possibility of gene therapy as a new treatment strategy. 1, 2 heart. Using this novel approach, we also studied the utilTargeted diseases are widespread, from single gene ity of the HVJ (hemagglutinating virus of Japan)-lipodeficiency diseases to more complex adult diseases. An some method for implantation of genetically modified attractive gene therapy approach is the implantation of cultured cardiac myocytes transfected with antisense genetically modified cultured cells. [3] [4] [5] [6] Cell grafting has ODN and a marker gene ex vivo as compared with direct emerged as an accepted approach for the delivery of transfer. First, we examined the cellular fate of grafted therapeutic agents to patients. More recently, the use of genetically modified cardiac myocytes transfected by the genetically modified cells for the delivery of recombinant HVJ-liposome method, conventional cationic liposome or molecules has also emerged as a powerful tool for ex vivo direct transfer. Since, apparently, one of the major targets gene therapy. The cell grafted strategy may be useful for of myocyte graft therapy is myocardial infarction, the gene therapy in the heart, since direct transfection of cellular fate of grafted cells in the infarcted myocardium foreign genes into the heart seems to be difficult. Thereis worth studying for future gene therapy in humans. fore, it is important to establish the potential for grafting Nevertheless, none of the reports mentioned the cellular of genetically modified cardiac myocytes as ex vivo gene fate of myocyte grafting in the myocardial infarction therapy. From this viewpoint, it is necessary to know the model. Therefore, in this study, the feasibility of geneticellular fate of genetically modified grafted cells. Therecally modified cardiac grafts into the myocardial infarcfore, in this study we employed genetically modified tion model was also evaluated.
Results
survived in the intact host heart. This fluorescence was We initially examined the cellular fate of grafts of genetispecifically due to modified myocyte grafts, but not to cally modified cardiac myocytes. Figure 1 shows a repcontamination of free FITC-labeled ODN, since injection resentative photograph of implanted genetically modiof supernatant after centrifugation of transfected myofied myocytes in host heart. The fluorescence following cytes resulted in no fluorescence in the heart (data not direct transfer disappeared within 24 h (Figure 1c) , while shown). All six rats (100%) transfected with FITC-labeled by the HVJ-liposome method the fluorescence was sus-ODN using the HVJ-liposome method exhibited evitained in the nuclei of cultured myocytes (Figure 1a) . dence of fluorescence for at least 1 week. Moreover, as Even on day 7, the fluorescence of cultured myocytes shown in Figure 2 , FITC-labeled ODN transfection by the transfected with FITC-labeled ODN ex vivo by the HVJ-HVJ-liposome method resulted in a significant increase liposome method was sustained around the injection site in fluorescence of the whole heart as compared to direct transfer ('naked') (P Ͻ 0.05) at 4 days after transfection. All 15 rats transfected with FITC-ODN in vivo and ex vivo (100%) survived, suggesting little toxicity in these procedures. To clarify whether the preferential survival of grafted cells is due to the use of the HVJ-liposome method or not, we also compared the fluorescence intensity in hearts transfected with FITC-labeled ODN by direct transfer, conventional cationic liposome (lipofection) or the HVJ-liposome method via direct needle injection. Interestingly, fluorescence in the hearts transfected with FITC-labeled ODN by the HVJ-liposome method was significantly higher than that by direct transfer and lipofection (HVJ, 517 ± 93 fluorescence intensity; lipofection 59 ± 16 fluorescence intensity; direct, 7 ± 32 fluorescence intensity, P Ͻ 0.01 lipofection versus direct; n = 6).
To apply the grafting of cardiac myocytes as a therapeutic strategy, we evaluated survival of implanted genetically modified cardiac myocytes by the HVJ-liposome method in a myocardial infarction model. Of importance, fluorescence was readily detected in the noninfarcted area ( Figure 3a ) and borderline zone (Figure 3b ) between the noninfarcted and infarcted area at 3 days after transfection by the HVJ-liposome method, whereas little fluorescence was observed in the infarcted area ( Figure 3c ). All six rats (100%) transfected with FITC-labeled ODN ( Figure 5a ), while little positive staining was detected in the infarcted area in rats (Figure 5b , n = 6). No staining was detected in rats grafted with myocytes transfected with control vector (n = 6) and untransfected rats (n = 6) (data not shown). In all animals, surface electrocardiograms failed to detect any appreciable differences in recording between untransfected and experimental rats (data not shown). Moreover, implantation of cardiac grafts did not alter mortality of infarcted rats. Four of 19 rats whose left coronary artery was ligated were dead within 24 h because of arrhythmia or heart failure. One of the rest was dead 2 days after and 13 rats (68%) survived over at least 7 days. There were no significant differences between operated infarcted animals with grafted myocytes and those without grafting (data not shown). Unfortunately, severe damage with inflammation and neutrophil accumulation in the myocardium was observed on hematoxylin-eosin staining even in rats injected with vehicle (BSS solution alone), as shown in Figure 6c . Although the needle injection itself caused severe damage to the myocardium (Figure 6b ), there was no evidence of inflammation attributable to the HVJ-liposome vector.
Figure 3 Fluorescence in heart of rats grafted with cardiac myocytes transfected with FITC-labeled ODN ex vivo in rat myocardial infarction model at 4 days after transfection by HVJ-liposome method. (a) Non-

Discussion infarcted area (× 200); (b) borderline zone area (× 200); (c) infarcted area (× 200).
Gene therapy in the field of cardiovascular disease would be useful for the treatment of many diseases, including the prevention of restenosis after angioplasty, myocardial exhibited apparent evidence of fluorescence in noninfarcted, but not infarcted areas for at least 1 week. These infarction and rejection in heart transplantation. Indeed, we and others have reported the successful prevention of observations were also confirmed by measurement of fluorescence as shown in Figure 4 . The level of fluorrestenosis after angioplasty using an ODN-based strategy and a transgene strategy. 7-14 Transfection of recombinant escence was significantly higher in the noninfarcted area than in the infarcted area (P Ͻ 0.05).
genes into blood vessels appears to be established in the realm of gene therapy. However, many unresolved probFinally, we employed implantation of cardiac myocytes transfected ex vivo with ␤-galactosidase gene as a lems still lie ahead in in vivo gene transfer into the heart. One attractive approach for gene therapy is the implanmarker by the HVJ-liposome method. Positive staining for ␤-galactosidase in the noninfarcted area was clearly tation of genetically modified cultured cells. [1] [2] [3] [4] [5] [6] Cell grafting has emerged as an accepted approach for the delivery observed 7 days after grafting of cardiac myocytes of therapeutic agents to patients. More recently, the use of genetically modified cells for the delivery of recombinant molecules has also emerged as a powerful tool for ex vivo gene therapy. For the application of ex vivo gene therapy to cardiac diseases, myoblast grafting has been reported. [4] [5] [6] Koh et al 5 previously reported the differentiation and long-term survival of C2C12 myoblast grafts in the heart introduced by direct injection, and that myoblasts transfected with transforming growth factor-␤ pro- fate and localization of grafted cells in the host heart. As shown in Figures 1 and 3 , cardiac myocytes transfected with FITC-labeled ODN demonstrated fluorescence in the host heart in vivo. It is easy to study the kinetics of survival of grafts might be increased. Interestingly, a previous report described the formation of gap junctions grafts in the host heart using FITC-labeled ODN transfected grafts presented in this study. Moreover, the HVJbetween the injected cultured rat neonatal myocytes and the native cardiac myocytes in the intact heart. 6 Thereliposome method is also useful for prolongation of the half-life and enhancement of the effects of ODN transfore, targeted expression of recombinant molecules in intracardiac grafts could induce a beneficial response in fected ex vivo (Figure 2) , consistent with direct injection data (unpublished observation).
the myocardium. For example, grafts expressing angiogenic factors (as exemplified by basic and acidic fibroOf importance, the present study showed survival of myocyte grafts in the noninfarcted and border-zone blast growth factor, TGF-␤, vascular endothelial growth factor) might induce neovascularization in a paracrine areas, but not in the infarcted area (Figures 3-5) . Probably, grafts in infarcted areas cannot survive because of manner. A more exciting application of intracardiac myocyte grafting lies in the potential replacement of the disthe lack of blood supply. If recanalization occurred, the eased myocardium. It is well known that ventricular carimmunogenicity of the HVJ-liposome method. The high transfection efficiency into myocardium of the HVJ-lipodiac myocytes in the adult mammal have no capacity to re-enter the cell cycle. Myocyte death due to infarction is some method by direct needle injection presented in this study also supports this hypothesis. consequently irreversible. Our present finding that adult myocyte grafts can survive in the host heart raises the
In conclusion, the present study demonstrated that the HVJ-liposome method is more efficacious for ODN delivpossibility that damaged myocardium could be replaced by implanted cardiac myocytes, potentially resulting in a ery by prolongation of the half-life of ODN, suggesting the usefulness for gene therapy in cardiac diseases. Using direct contribution to the cardiac work force. Alternatively, cardiac myocyte grafts transfected with antisense the HVJ-liposome method, survival of adult cardiac myocyte grafts transfected with ODN or genes ex vivo in ODN targeting unknown genes that maintain myocytes during the differentiated stage outside the cell cycle, the myocardium presents a potential ex vivo gene therapy in cardiovascular diseases as a stable platform for might induce the replication of cardiac myocytes, resulting in rapid healing in myocardial infarction. Overexpression of recombinant molecules in the heart. Furthermore, the survival of implanted genetically modified all, this study is the first to provide evidence for the survival of adult genetically modified cardiac myocytes in cardiac myocytes in the noninfarcted area provides new information for the local delivery of recombinant mola myocardial infarction model. Implantation of grafts in infarcted areas should be avoided, since our current data ecules to the heart in gene therapy. revealed that survival of grafts was limited to only the noninfarcted area. Injection of grafts seems not to affect
Materials and methods
cardiac function, since we found no significant change in ECG after transfection.
Oligonucleotides Since to achieve gene therapy in the heart, it is FITC-labeled phosphorothioate ODN were provided by important to establish an efficient technique for gene Clontech, Palo Alto, CA, USA. FITC was labeled on the and/or ODN transfection into cardiac myocytes in vivo, 3′ and 5′ ends of the ODN (16 base pairs: 5′-CCT-TGAseveral investigators have reported gene transfer to the AGG-GAT-TTC-CCT-CC-3′). The ODN were lyophilized, heart using direct injection of plasmid DNA, [15] [16] [17] [18] [19] [20] and resuspended in PBS, and quantified by spectrophotoadenoviral transfer. [21] [22] [23] [24] [25] However, using direct injection metry.
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of plasmid DNA, the number of transfected myocytes appeared to be too small for gene delivery, and myocytes Construction of plasmid also suffered toxicity due to DNA itself. [15] [16] [17] [18] [19] [20] On the other ␤-Galactosidase expression plasmid and control plasmid: hand, adenoviral vector seems to be very efficient for
We obtained ␤-galactosidase gene expression vector from gene transfer via direct injection 22, 23 and coronary a commercially available source (Promega, Madison, WI, infusion, 21 but there are still disadvantages such as USA). ␤-Galactosidase expression vector is driven by the inflammation and the products of neutralizing antibody. 3 SV 40 promoter. As the control, we constructed a control Therefore, it is becoming important to establish efficient expression vector driven by the SV 40 promoter without ODN and gene delivery methods into the adult heart for the ␤-galactosidase gene. gene therapy of cardiac diseases. In this study, we also showed that transfection of genetically modified grafts by the HVJ-liposome method resulted in a higher fluorPreparation of HVJ liposomes HVJ (Sendai virus; Z strain) was propagated in chorioescence level than by direct transfer. This prolonged and enhanced effect of ODN transfected by the HVJ-liposome allantoic fluid of fertilized eggs. 7-9 Briefly, HVJ was collected by centrifugation at 27 000 g for 40 min and susmethod is consistent with our previous findings in blood vessels. 8, 9 Although the detailed mechanisms of the HVJpended in BSS (−) (137 mm NaCl, 5.4 mm KCl, 10 mm Tris-HCl pH 7.6) overnight. This procedure was repeated liposome method are not yet fully understood, this method utilizes fusion between the lipid membrane and at least twice. The resuspended HVJ was stored at −4°C, and used within 1 week after purification. The hemaggluthe cell membrane. 8,9,26 HVJ has two surface glycoproteins: (1) HN protein that is associated with attachtinating activity of HVJ was determined as described previously. 7-10 One A 540 of HVJ suspension contained 1 ment between the HVJ-liposome complex containing ODN and myocytes; and (2) F protein that causes fusion mg/ml protein and was equivalent to 15 000 HAU/ml as an index of fusogenic property. The preparation of the between the lipid membrane and the cell membrane, resulting in rapid release of ODN or transgenes in lipo-HVJ-liposome complex has been previously described.
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Briefly, phosphatidylserine, phosphatidylcholine, and somes into the cytoplasm. Although in the ordinary pathway without vector, ODN are trapped in endosomes cholesterol were mixed in a weight ratio of 1:4.8:2. The lipid mixture (10 mg) was deposited on the sides of a resulting in lysosomal degradation, in this pathway utilizing the HVJ-liposome vector, the endocytosis step is flask by removal of tetrahydrofuran in a rotary evaporator. Dried lipid was hydrated in 200 l of balanced salt avoided. Unfortunately, the exact mechanisms of persisting cell fluorescence of genetically modified grafted solution (BSS; 137 mm NaCl, 5.4 mm KCl, 13 mm TrisHCl, pH 7.6) containing FITC-labeled ODN (10 nmol) or myocytes by the HVJ-liposome method have not been fully clarified in this study. It seems to be due to several DNA-HMG (high mobility group)-1 complex (200 g:64 g), which had previously been incubated at 20°C for reasons: (1) a greater number of transfected grafted cells due to the high transfection efficiency of the HVJ-lipo-1 h. Liposomes were prepared by shaking and sonication. Purified HVJ (Z strain) was inactivated by UV irradiation some method; (2) a greater amount of FITC-labeled ODN in transfected grafted cells by the HVJ-liposome method;
(110 erg/mm 2 /s) for 3 min just before use. The liposome suspension (0.5 ml, containing 10 mg lipid) was mixed and (3) lower immunogenicity of the HVJ-liposome method, since there is no report on the apparent with HVJ (35 000 hemagglutinating units) in a total vol-ume of 2 ml of BSS. The mixture was incubated at 4°C and 5% fetal calf serum, and 20 l of solution (10 000 cells) immediately injected into the apex of the hearts of for 10 min and then for 30 min with gentle shaking at 37°C. Free HVJ was separated from the HVJ-liposome anesthetized rats. Briefly, Sprague-Dawley rats (300-400 g; Charles River Breeding Laboratories, Raleigh, NC, complex by sucrose density gradient centrifugation. The top layer of the sucrose gradient was collected for use. USA) were anesthetized with an intraperitoneal injection of sodium pentobarbital (0.1 ml/100 mg). Rats were intuFor gene transfer, we utilized HMG-1 to enhance the migration of plasmid DNA into the nucleus. 27 However, bated and connected to a respirator. HVJ-liposome complex 20-30 l was carefully injected directly into the apex HMG-1 has not been utilized for ODN transfer, since ODN can easily migrate into the nucleus without HMG-1.
of the heart with a 30-gauge needle through a left lateral thoracotomy. Rats were killed, perfusion-fixed with 4% paraformaldehyde, followed by processing in a standard Grafting of myocytes transfected ex vivo into myocardium manner, and observed by microscopy at 24 h, 3, 5 and 7 days after grafting. Sections were examined by fluorAdult rat ventricular myocytes were prepared as reported previously 28 with several modifications. 29 escence microscopy, after staining in eriochrome black T solution. Elastic fibers stained dark red and were readily Hearts were excised from anesthetized and heparinized Sprague-Dawley adult rats (300-400 g) and mounted on distinguishable from the specific FITC-labeled ODN by treatment with eriochrome black T solution.
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a modified Langendorff-perfusion apparatus via an aortic cannula. Perfusion and dissociation of the heart were perWe also performed measurement of fluorescence to confirm the survival of grafts transfected with FITC-labformed at 80 cm H 2 O with an oxygenated Krebs-Henseleit medium, containing collagenase type I and IV eled ODN by the HVJ-liposome method and direct transfer. The whole heart with grafts transfected ex vivo was (Boehringer, Mannheim, Germany, 400 U/ml), trypsin (0.012%), and dispase (0.012%) as dissociating enzymes.
homogenized in 1 ml of PBS buffer, centrifuged, and fluorescence was measured in 400 l of supernatant. IntenAfter 20-30 min, the atria and major vessels were removed and the ventricle was minced and incubated in sity of fluorescence in the whole heart transfected by the HVJ-liposome method and without vector were examthe oxygenated enzyme solution for another 10 min. After filtration through a nylon mesh, the cell homogenined. The hearts from grafted rats were subjected to measurement. They were homogenized in 1 ml of PBS ate was placed on top of a continuous percoll gradient (density range: 0.876-0.450 g/ml) and separated with a buffer, centrifuged and 400 l of the supernatant was used for measurement with a fluorescence meter (RF1500 special cell separation centrifuge (Buehler, Tuebingen, Germany) into a heart muscle cell fraction and a top layer spectrofluorophotometer, Shimazu, Kyoto, Japan) (excitation, 493 nm; emission, 520 nm). with nonmuscle cells. The cell suspension was centrifuged at 40 g for 5 min, and the pellet was resuspended in medium 199 with Eagle's salts, penicillin, streptoDirect transfection of FITC-labeled ODN into the myocardium mycin, and 4% fetal calf serum. Before cell plating, 6 cm plastic dishes were coated with 60 g/ml laminin at 37°C
We performed measurement of fluorescence quantitatively to compare the efficiency of FITC-ODN transfection for 24 h. Cells were preplated for 2 h in medium supplemented with 4% fetal calf serum to remove non-adherwith the HVJ-liposome method (1 m), lipofection method (1 m) and without vector (direct transfer: 10 m) ent cells. Then the medium was changed to 0.1% fetal calf serum. Cells were maintained in a 5% CO 2 atmosphere via direct needle injection into the myocardium. Briefly, 20-30 l of HVJ-liposome complex containing FITC-labin medium 199 with Eagle's salts, penicillin, streptomycin, and 0.1% fetal calf serum.
eled ODN (1 m), of lipofection complex containing FITC-labeled ODN (1 m) or BSS containing FITC-labeled Rat ventricular cardiomyocytes collected by the above method were transfected as follows: (1) HVJ-liposome ODN (10 m) was carefully injected directly into the apex of the heart with a 30-gauge needle through a left lateral method; incubation with HVJ-liposome complex containing FITC-labeled ODN (1 m) at 4°C for 10 min and at thoracotomy. The hearts were harvested at 4 days after transfection. Hearts were homogenized in 1 ml of PBS 37°C for 30 min; and (2) direct transfer; incubation with FITC-labeled ODN only in BSS (10 m) at 4°C for 10 min buffer, centrifuged and 400 l of the supernatant was used for measurement with a fluorescence meter, as and at 37°C for 30 min. Myocardial cell viability was not changed by transfection of FITC-ODN with the HVJ-lipodescribed above. some method or direct transfer (data not shown). Cells were washed again with BSS and maintained subTransfer into the myocardial infarction model For the myocardial infarction model, the left coronary sequently in medium 199 containing 0.1% FCS, and fixed in 4% paraformaldehyde immediately, 24 h, 3, 5 and 7 artery (LCA) was ligated within 2 to 3 mm of the proximal aorta. 30,31 Ventricular premature beats, ventricular days after transfection. Cells were observed by fluorescence microscopy to compare the HVJ-liposome tachycardia, and ventricular fibrillation occurred after ligation and ST segment elevation was also detected in the method with direct transfer.
For myocyte grafting, adherent cultured myocytes ECG. All animals examined had normal P-QRS coupling and exhibited normal sinus rhythm with an anesthetized were gently aspirated and centrifuged (35 g, 5 min). Collected myocytes were transfected either by the HVJ-lipoheart rate of approximately 400 beats per min. Recanalization and reperfusion were not performed. After LCA some method (1 m) or direct transfer (10 m) for 10 min at 4°C and incubated for 30 min at 37°C. Transfected occlusion, transfection of the HVJ-liposome complex containing (1) FITC-labeled ODN (1 m); (2) ␤-galactosidase myocytes grafts were carefully washed with medium four times 1 h after transfection to remove remaining cDNA vector (10 g/ml); or (3) control vector (10 g/ml) was performed. Implantation of genetically modified car-FITC-ODN completely. Then, transfected cultured myocytes were resuspended in medium 199 with Eagle's salts diac myocytes transfected ex vivo was performed as
